150 related articles for article (PubMed ID: 8382719)
1. Recombinant immunoblot assays for hepatitis C in human immunodeficiency virus type 1-infected US Navy personnel.
Bryan JP; Sjogren MH; Malone JL; MacArthy P; Kao TC; Wagner K; Sheffield J; Smith E; Perine PL
J Infect Dis; 1993 Mar; 167(3):715-9. PubMed ID: 8382719
[TBL] [Abstract][Full Text] [Related]
2. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
Marcellin P; Martinot-Peignoux M; Elias A; Branger M; Courtois F; Level R; Erlinger S; Benhamou JP
J Infect Dis; 1994 Aug; 170(2):433-5. PubMed ID: 7518489
[TBL] [Abstract][Full Text] [Related]
6. Low risk of sexual transmission of hepatitis C virus in Somalia.
Watts DM; Corwin AL; Omar MA; Hyams KC
Trans R Soc Trop Med Hyg; 1994; 88(1):55-6. PubMed ID: 8154002
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.
Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L
Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
9. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in chronic liver disease in Somalia.
Aceti A; Taliani G; Bruni R; Sharif OS; Moallin KA; Celestino D; Quaranta G; Sebastiani A
Am J Trop Med Hyg; 1993 Apr; 48(4):581-4. PubMed ID: 7683179
[TBL] [Abstract][Full Text] [Related]
11. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Oshita M; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1993 Feb; 17(2):170-4. PubMed ID: 8383157
[TBL] [Abstract][Full Text] [Related]
12. Recombinant immunoblot assay first and second generations on 732 blood donors reactive for antibodies to hepatitis C virus by ELISA. The Hepatitis Study Group of the French Society of Blood Transfusion.
Couroucé AM; Janot C
Vox Sang; 1991; 61(3):177-80. PubMed ID: 1666933
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems.
Nübling CM; von Wangenheim G; Staszewski S; Löwer J
J Med Virol; 1994 Sep; 44(1):49-53. PubMed ID: 7798885
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays.
Couroucé AM; Le Marrec N; Girault A; Ducamp S; Simon N
Transfusion; 1994 Sep; 34(9):790-5. PubMed ID: 8091469
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
18. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
Hyland CA; Kearns S; Young IF; Battistutta D; Morgan CL
Transfus Med; 1992 Sep; 2(3):207-13. PubMed ID: 1285010
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus antibody in coagulopathic patients: ELISA and RIBA methods.
Chistolini A; Filoni V; Dragoni F; Piro L; Mazzucconi MG; Isacchi G
Haematologica; 1993; 78(4):252-4. PubMed ID: 7507458
[TBL] [Abstract][Full Text] [Related]
20. New-generation RIBA hepatitis C strip immunoblot assays.
Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
